Shenzhen Salubris Pharmaceuticals Co., Ltd.
尊龙凯时-人生就是搏!
join us
CN
Home page
About Us
Profile
Affiliates/Subsidiaries
Development History
Quality Management
Contact Us
Legal Statement
Adverse Reaction Report
Science and Technology
R&D platform
R&D pipeline
Therapeutic Field
International Business
APIs
Finished Products
Medical device
Download product list
Contact
News Center
News & Trends
Public information
News & Trends
30
2018-01
The tide of capital increase welcomes a good start
Recently, Salubris has successively increased its capital and invested in Sichuan Jinjiang Electronic Science and Technology Co., Ltd. ("Jinjiang Electronic") and KingstronBio (Changshu) Co., Ltd. ("KingstronBio").
02
2017-05
Warmly congratulate Salubris on the formal establishment of its first American subsidiary
On May 1, local time in Maryland, USA, Salubris Biotherapeutics, Inc., a wholly-owned subsidiary of Genekey Biotech (Chengdu) Co., Ltd., held its opening ceremony in Gaithersburg, Maryland, USA. Salubris Biotherapeutics, Inc. was the first American s
目前在第
9
页,
共有
9
页,
共有
50
条记录
第一页
上一页
5
6
7
8
9
下一页
最后一页
跳转到
页